Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

ObjectiveThe management of cardiotoxicity concerning the use of oral antineoplastic agents (OAAs) is a challenge for healthcare professionals. Our objective was to create a comprehensive medication management guide with dose adjustment recommendations on OAAs concerning cardiotoxic and lipid metabol...

Full description

Bibliographic Details
Main Authors: Elena Ramos-Ruperez, Vicente Escudero-Vilaplana, Paula Ruiz-Briones, Roberto Collado-Borrell, Cristina Villanueva-Bueno, José Luis Revuelta-Herrero, Eva González-Haba, Xandra Garcia-Gonzalez, Sara Ibañez-Garcia, Sara Perez-Ramirez, Eduardo Zatarain-Nicolás, Ana Herranz, María Sanjurjo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
adverse event
cancer
cardiology
cardiotoxicity
oral antineoplastic therapy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1220305/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1220305/full

Similar Items